Fulcrum Therapeutics News and Activities

Presence

Fulcrum Therapeutics develops medicines for genetically defined diseases. It offers drug discovery and clinical development services for muscle, blood, and rare disease patients, healthcare providers, and research partners.

Fulcrum Therapeutics products and services overview:

Drug discovery
Clinical development
Rare disease therapies
Muscle disease treatments
Blood disorder treatments
Precision medicine

Revenue: ~$6 million

Employees: 130

Headquarters: Cambridge, United States (USA)

Fulcrum Therapeutics is one of the...

Fulcrum Therapeutics is a company listed under the stock ticker FULC (US).

Executives

View the org chart displaying its 32 main executives

Most searched biographies at Fulcrum Therapeutics

Popular executive movements at Fulcrum Therapeutics

Josh Lehrer has joined the company as Chief Financial Officer and Director (posted on April 27 2026).
Alan Musso, Chief Financial Officer, has left the company (posted on April 27 2026).
Lisa Percival has joined the company as Chief Regulatory Officer (posted on November 14 2025).

Create your alert
to follow the executive moves at Fulcrum Therapeutics.